RXST
RxSight, Inc.
$5.85
+0.86%
2026-05-08
About RxSight, Inc.
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Key Fundamentals
Forward P/E
-9.39
EPS (TTM)
$-1.13
ROE
-14.0%
Revenue Growth (YoY)
-18.9%
Profit Margin
-29.0%
Debt/Equity
4.00
Price/Book
0.86
Beta
1.24
Market Cap
$237.2M
Avg Volume (10D)
726K
Recent Breakout Signals
No recent breakout signals detected for RXST.
Recent Price Range (60 Days)
60D High
$9.07
60D Low
$5.30
Avg Volume
756K
Latest Close
$5.85
Get breakout alerts for RXST
Sign up for Breakout Scanner to receive daily notifications when RXST triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
RxSight, Inc. (RXST) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors RXST daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. RXST operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.